Related Experiment Video

Updated: Jun 8, 2026

Production, Crystallization and Structure Determination of C. difficile PPEP-1 via Microseeding and Zinc-SAD
13:34

Production, Crystallization and Structure Determination of C. difficile PPEP-1 via Microseeding and Zinc-SAD

Published on: December 30, 2016

Peptide inhibitors targeting Clostridium difficile toxins A and B

Sanofar J Abdeen, Rebecca J Swett, Andrew L Feig

    ACS Chemical Biology
    |September 25, 2010
    PubMed

    Insights

    Researchers identified novel peptides that inhibit Clostridium difficile Toxin A, offering a new strategy against hospital-acquired infections. These findings could lead to improved treatments for antibiotic-associated diarrhea.

    Area of Science:

    • Microbiology
    • Toxicology
    • Drug Discovery

    Background:

    • Clostridium difficile infections cause severe hospital-acquired diarrhea.
    • Current treatments have high relapse rates and promote resistance.
    • Targeting virulence factors like C. difficile Toxin A is a promising therapeutic approach.

    Purpose of the Study:

    • To identify novel peptide inhibitors targeting the catalytic domain of C. difficile Toxin A.
    • To explore new therapeutic strategies against C. difficile infections.

    Main Methods:

    • Phage display was employed to screen for peptides binding to C. difficile Toxin A.
    • Quantitative binding and inhibition assays were performed.
    • Fragment-based computational docking elucidated peptide binding modes.

    Main Results:

    • Several identified peptides demonstrated potent inhibition of C. difficile Toxin A.
    • Binding modes within the toxin's active site were computationally elucidated.
    • The peptides show potential as lead compounds for new inhibitors.

    Conclusions:

    • Novel antitoxin peptides targeting C. difficile Toxin A were identified.
    • These peptides represent promising lead compounds for developing peptidomimetic inhibitors.
    • This research offers a new avenue for combating C. difficile-associated diseases.

    More Related Videos

    A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment12:58

    A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

    Published on: May 25, 2017

    Related Concept Videos

    Inhibitors of Gram-positive Cell Wall Synthesis01:23

    Inhibitors of Gram-positive Cell Wall Synthesis

    Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
    Inhibitors of Bacterial Protein Synthesis01:25

    Inhibitors of Bacterial Protein Synthesis

    Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
    Botulism01:22

    Botulism

    Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
    Bacterial Toxins01:12

    Bacterial Toxins

    Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
    Drugs for Treatment of Constipation-Predominant IBS01:21

    Drugs for Treatment of Constipation-Predominant IBS

    Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
    Antimicrobial Proteins01:23

    Antimicrobial Proteins

    Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
    Interferons
    Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...